Skip to content
Discover expert travel advice, loyalty program strategies, …

Zimbabwe Declines ‘One-Sided’ American Health Aid Package Due to Data Concerns

Health funding illustration
The proposed American funding was intended for initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a significant US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of Washington's insistence on sensitive biological samples.

This move was revealed after a official document dated December was disclosed, indicating that President Emmerson Mnangagwa felt the deal was "lopsided".

An official representative has since explained that the US was seeking biological samples for scientific study and commercial gain but was not willing to share the benefits from future vaccines.

"We will now turn to the difficult and regrettable process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has called for continued dialogue to secure a agreement agreeable to all parties so the country's vital HIV programme can proceed.

Broader Background

This development comes after a similar situation in neighbouring Kenya, where a court halted a similar deal with the US following concerns were raised about the security of citizens' medical information.

After resuming the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).

The agency had administered aid for the American government, but Trump argued its spending was "wasteful" and his administration was seeking direct bilateral agreements to enhance transparency and responsibility.

As per reports, Sixteen African countries have to date agreed to these new health pacts, representing over $18.3bn in committed funds.

Details of the Rejected Agreement

The money for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this cooperation would have delivered immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," Tremont commented.

However, official spokesman Nick Mangwana said the arrangement was "unfair".

"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, without any equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.

"In essence, our nation would provide the raw materials for scientific discovery with no certainty that the end products would be accessible to our population if a new pandemic emerge."

Sovereignty and International Frameworks

Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were disrupting frameworks previously established through the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with future pandemics.

"This system is intended to guarantee that when a nation contributes its data, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised solely by those with the capability to create them."

The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We are open to ongoing dialogue with our American counterparts on how future co-operation could be designed in a manner that respects the independence and interests of both nations."

Medical Community Reaction

Medical experts expressed it recognised the government's concerns, but suggested that negotiations must proceed considering much of the country's Aids initiatives depended on international support.

"If specific concerns arise, such as those relating to information security or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," the group commented.

The situation highlights the complex debate between accepting crucial foreign assistance and safeguarding a country's data in an increasingly data-driven world.

By

Anna Davis

A seasoned travel writer and rewards expert, Elara shares insights on maximizing loyalty programs and exploring Canada affordably.

Bonus Point Canada

Type to search articles.